Drugs whose targets have genetic evidence to support efficacy and safety are more likely to
be approved after clinical development. In this paper, we provide an overview of how natural …

Genetic studies of disease progression can be used to identify factors that may influence
survival or prognosis, which may differ from factors that influence on disease susceptibility. …

Summary statistics for genome-wide association studies (GWAS) are increasingly available
for downstream analyses. Meanwhile, the popularity of causal inference methods has grown …

Identification of unintended drug effects, specifically drug repurposing opportunities and
adverse drug events, maximizes the benefit of a drug and protects the health of patients. …

CORRESPONDENCE lifetime smoking score were also associated with increased risk of
severe COVID-19 with respiratory failure and hospitalization with COVID-19 (Figure). Similar …

Background Epidemiological studies have reported conflicting findings on the potential adverse
effects of long-term antihypertensive medication use on cancer risk. Naturally occurring …

Mendelian randomization (MR) estimates the causal effect of exposures on outcomes by
exploiting genetic variation to address confounding and reverse causation. This method has a …

Background: Lipoprotein-related traits have been consistently identified as risk factors for
atherosclerotic cardiovascular disease, largely on the basis of studies of coronary artery …

Background Evidence concerning the potential repurposing of antihypertensives for Alzheimer’s
disease prevention is inconclusive. We used Mendelian randomization, which can be …

Traditionally, heritability has been estimated using family-based methods such as twin studies.
Advancements in molecular genomics have facilitated the development of methods that …